New iqvia study demonstrates cost and time savings of decentralized trials

Research triangle park, n.c.--(business wire)--iqvia™ (nyse:iqv), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced new evidence that decentralized clinical trials (dct) deliver measurable benefits for patients, sites and sponsors. with one of the first fact-based examinations of the return on investment of dcts, iqvia offers tangible data that can help sponsors calculate the overall benefit of bui
IQV Ratings Summary
IQV Quant Ranking